Literature DB >> 7192495

Synergism of combined lithium-neuroleptic therapy: a double-blind, placebo-controlled case study.

L B Bigelow, D R Weinberger, R J Wyatt.   

Abstract

The authors describe a longitudinal, placebo-controlled study of the response to drug treatment of a 62-year-old schizoaffective patient hospitalized for 40 years. While neither lithium nor a neuroleptic drug alone was effective, both drugs administered simultaneously led to the gradual extinction of a pronounced behavioral cycle and the disappearance of manifest psychosis. The authors suggest a synergistic interaction between the two drugs and stress the need for sustained trials of the combination in patients with similar behavioral cycles.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7192495     DOI: 10.1176/ajp.138.1.81

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

Review 1.  Pharmacologic treatment of schizoaffective disorder.

Authors:  P E Keck; S L McElroy; S M Strakowski; S A West
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

2.  A within-subject consideration of the psychotic spectrum disorder concept in a patient in remission associated with cortical gray matter recovery.

Authors:  Herbert Y Meltzer; Min Young Sim; Adam Anderson; Christopher Cannistraci; Karu Jayathilake; Daniel Barrett Share; Myung Lee
Journal:  CNS Neurosci Ther       Date:  2018-07       Impact factor: 5.243

Review 3.  Thioridazine for schizophrenia.

Authors:  M Fenton; J Rathbone; J Reilly; A Sultana
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 4.  Lithium for schizophrenia.

Authors:  Stefan Leucht; Bartosz Helfer; Markus Dold; Werner Kissling; John J McGrath
Journal:  Cochrane Database Syst Rev       Date:  2015-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.